首页> 外文OA文献 >Inflammatory cytokines TNFα and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators

【2h】

Inflammatory cytokines TNFα and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators

机译：炎症细胞因子TNFα和IL-17增强囊性纤维化跨膜电导调节剂调节剂的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tayyab Rehman; Philip H. Karp; Ping Tan; Brian J. Goodell; Alejandro A. Pezzulo; Andrew L. Thurman; Ian M. Thornell; Samantha L. Durfey; Michael E. Duffey; David A. Stoltz; Edward F. McKone; Pradeep K. Singh; Michael J. Welsh;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cystic fibrosis transmembrane conductance regulator biomarkers in real life: Can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy? [J] . Therapeutic advances in respiratory disease. . 2015,第4期

机译：现实生活中的囊性纤维化跨膜电导调节剂生物标志物：我们能否评估囊性纤维化跨膜电导调节剂疗法的个体疗效？
2. Regulation of Gap Junctional Communication by a Pro-Inflammatory Cytokine in Cystic Fibrosis Transmembrane Conductance Regulator-Expressing but Not Cystic Fibrosis Airway Cells [J] . Marc Chanson, Pierre-Yves Berclaz, Isabelle Scerri, American Journal of Pathology . 2001,第5期

机译：炎症性细胞因子在囊性纤维化跨膜电导调节剂表达而不是囊性纤维化气道细胞中促炎性细胞因子的间隙连接通讯的调节。
3. Cystic Fibrosis Foundation Pulmonary Guidelines Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis [J] . Ren Clement L., Morgan Rebecca L., Oermann Christopher, Annals of the American Thoracic Society . 2018,第3期

机译：囊性纤维化基础肺指导利用囊性纤维化跨膜电导调节剂调节剂治疗患者囊性纤维化
4. Cystic fibrosis transmembrane conductance regulator gene mutations cause 'black' pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis [C] . A. L. BRODERICK, H. WITTENBURG, M. A. LYONS, Falk Symposium . 2004

机译：囊性纤维化跨膜电导调节剂基因突变引起'黑色'颜料胆结石形成：来自小鼠模型的新见解，以及对囊性纤维化治疗干预的影响
5. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies in Cystic Fibrosis: A Retrospective Evaluation of a Nationwide Specialty Pharmacy Database [D] . Mehta, Zumi . 2020

机译：囊性纤维化跨膜电导调节剂调节剂患者囊性纤维化：全国特色药房数据库的回顾性评估
6. Regulation of Gap Junctional Communication by a Pro-Inflammatory Cytokine in Cystic Fibrosis Transmembrane Conductance Regulator-Expressing but Not Cystic Fibrosis Airway Cells [O] . Marc Chanson, Pierre-Yves Berclaz, Isabelle Scerri, 2001

机译：炎症性细胞因子在囊性纤维化跨膜电导调节剂表达而不是囊性纤维化气道细胞中促炎性细胞因子的间隙连接通讯的调节。
7. Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells [O] . Chanson, Marc, Berclaz, Pierre-Yves, Scerri, Isabelle, 2001

机译：在表达囊性纤维化跨膜电导调节剂而不是囊性纤维化气道细胞中由促炎细胞因子调节间隙连接通讯

Inflammatory cytokines TNFα and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators

著录项

引文网络

相似文献

相关主题

期刊订阅